aTyr Pharma Stock Forecast, Price & News

aTyr Pharma (NASDAQ:LIFE) Frequently Asked Questions

Is aTyr Pharma a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for aTyr Pharma in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" aTyr Pharma stock.
View analyst ratings for aTyr Pharma or view top-rated stocks.

What stocks does MarketBeat like better than aTyr Pharma?

Wall Street analysts have given aTyr Pharma a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but aTyr Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting aTyr Pharma?

aTyr Pharma saw a decrease in short interest in September. As of September 30th, there was short interest totaling 1,560,000 shares, a decrease of 42.4% from the September 15th total of 2,710,000 shares. Based on an average daily volume of 5,320,000 shares, the days-to-cover ratio is presently 0.3 days.
View aTyr Pharma's Short Interest.

When is aTyr Pharma's next earnings date?

aTyr Pharma is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for aTyr Pharma.

How were aTyr Pharma's earnings last quarter?

aTyr Pharma, Inc. (NASDAQ:LIFE) issued its quarterly earnings data on Monday, August, 9th. The biotechnology company reported ($0.64) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.51) by $0.13. aTyr Pharma had a negative net margin of 155.18% and a negative trailing twelve-month return on equity of 75.60%.
View aTyr Pharma's earnings history.

How has aTyr Pharma's stock been impacted by COVID-19 (Coronavirus)?

aTyr Pharma's stock was trading at $3.03 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LIFE shares have increased by 182.8% and is now trading at $8.57.
View which stocks have been most impacted by COVID-19.

When did aTyr Pharma's stock split? How did aTyr Pharma's stock split work?

Shares of aTyr Pharma reverse split on Monday, July 1st 2019. The 1-14 reverse split was announced on Friday, June 28th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 28th 2019. An investor that had 100 shares of aTyr Pharma stock prior to the reverse split would have 7 shares after the split.

What price target have analysts set for LIFE?

7 analysts have issued 1-year price objectives for aTyr Pharma's shares. Their forecasts range from $15.00 to $22.00. On average, they anticipate aTyr Pharma's share price to reach $19.00 in the next twelve months. This suggests a possible upside of 121.7% from the stock's current price.
View analysts' price targets for aTyr Pharma or view top-rated stocks among Wall Street analysts.

Who are aTyr Pharma's key executives?

aTyr Pharma's management team includes the following people:

• Sanjay S. Shukla, President, Chief Executive Officer & Director (LinkedIn Profile)
• Jill M. Broadfoot, Chief Financial Officer
• Leslie Nangle, Vice President-Research
• Andrew B. Cubitt, Vice President-External Scientific Alliances
• Ashlee Dunston, Director-Investor Relations & Communications

What is Sanjay Shukla, M.D, M.S's approval rating as aTyr Pharma's CEO?

3 employees have rated aTyr Pharma CEO Sanjay Shukla, M.D, M.S on Glassdoor.com. Sanjay Shukla, M.D, M.S has an approval rating of 100% among aTyr Pharma's employees. This puts Sanjay Shukla, M.D, M.S in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of aTyr Pharma's key competitors?

Some companies that are related to aTyr Pharma include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Waters (WAT), Charles River Laboratories International (CRL), PerkinElmer (PKI), Bio-Techne (TECH), Bruker (BRKR), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and BG Medicine (BGMD).
View all of LIFE's competitors.

What other stocks do shareholders of aTyr Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other aTyr Pharma investors own include Wynn Resorts (WYNN), Biocept (BIOC), SCYNEXIS (SCYX), Idera Pharmaceuticals (IDRA), OPKO Health (OPK), Precigen (PGEN), QUALCOMM (QCOM), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX) and Aldeyra Therapeutics (ALDX).

When did aTyr Pharma IPO?

(LIFE) raised $76 million in an IPO on Thursday, May 7th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Citigroup acted as the underwriters for the IPO and BMO Capital Markets and William Blair were co-managers.

What is aTyr Pharma's stock symbol?

aTyr Pharma trades on the NASDAQ under the ticker symbol "LIFE."

How do I buy shares of aTyr Pharma?

Shares of LIFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is aTyr Pharma's stock price today?

One share of LIFE stock can currently be purchased for approximately $8.57.

How much money does aTyr Pharma make?

aTyr Pharma has a market capitalization of $145.00 million and generates $10.45 million in revenue each year. The biotechnology company earns $-16.22 million in net income (profit) each year or ($1.77) on an earnings per share basis.

How many employees does aTyr Pharma have?

aTyr Pharma employs 42 workers across the globe.

When was aTyr Pharma founded?

aTyr Pharma was founded in 2005.

What is aTyr Pharma's official website?

The official website for aTyr Pharma is www.atyrpharma.com.

Where are aTyr Pharma's headquarters?

aTyr Pharma is headquartered at 3545 JOHN HOPKINS COURT SUITE 250, SAN DIEGO CA, 92121.

How can I contact aTyr Pharma?

aTyr Pharma's mailing address is 3545 JOHN HOPKINS COURT SUITE 250, SAN DIEGO CA, 92121. The biotechnology company can be reached via phone at (858) 731-8389 or via email at [email protected].